AXSOME THERAPEUTICS INC. - COMMON STOCK

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USA

05 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission

03 مارس 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics to Participate in Upcoming Investor Conferences

26 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors

24 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

21 فبراير 2025 11:16:01 بحسب NetDania Notify

Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

18 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

11 فبراير 2025 10:02:00 بحسب NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

10 فبراير 2025 09:45:13 بحسب NetDania Notify

Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation

10 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

06 فبراير 2025 09:55:37 بحسب NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

05 فبراير 2025 09:45:07 بحسب NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

04 فبراير 2025 10:19:52 بحسب NetDania Notify

Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

31 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

30 يناير 2025 15:45:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

30 يناير 2025 09:45:15 بحسب NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

27 يناير 2025 10:08:34 بحسب NetDania Notify

Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18

22 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue

13 يناير 2025 07:00:01 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation

30 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy

26 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire